S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/RA Capital Management/Q2 2024

RA Capital Management

Period: Q2 2024 Β· Filed: 2024-08-14
View on SEC EDGAR β†—
AUM
$7.56B
Total portfolio value
Positions
78
Reported securities
Top Holding
ASND
18.2% $1.38B
QoQ Changes
+8 / -8
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2024-08-14) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
ASNDASCENDIS PHARMA A/S - ADR$1.38B18.23%$133.98$274.50+104.9%
18.2%
PCVXVAXCYTE INC$619.5M8.19%$76.94$58.39-24.1%
8.2%
JANXJANUX THERAPEUTICS INC$383.9M5.08%$41.72$15.54-62.8%
5.1%
LEGNLEGEND BIOTECH CORP-ADR$332.5M4.40%$46.02$29.91-35.0%
4.4%
RYTMRHYTHM PHARMACEUTICALS INC$249.8M3.30%$42.67$114.17+167.6%
3.3%
BIIBBIOGEN INC$227.7M3.01%$231.77$216.12-6.8%
3.0%
CLYMELIEM THERAPEUTICS INC$223.4M2.95%$7.05$12.90+83.0%
3.0%
RXSTRXSIGHT INC$222.3M2.94%$56.80$5.61-90.1%
2.9%
RNAMAVIDITY BIOSCIENCES INC$220.6M2.92%β€”β€”
2.9%
DYNDYNE THERAPEUTICS INC$213.5M2.82%$35.49$23.07-35.0%
2.8%
GERNGERON CORP$195.9M2.59%$4.34$1.36-68.7%
2.6%
PEPGPEPGEN INC$170.6M2.26%$17.91$1.76-90.2%
2.3%
TYRATYRA BIOSCIENCES INC$166.6M2.20%$17.28$30.62+77.2%
2.2%
EVHEVOLENT HEALTH INC - A$162.8M2.15%$18.41$5.71-69.0%
2.1%
EWTXEDGEWISE THERAPEUTICS INC$160.4M2.12%$19.38$39.56+104.1%
2.1%
NAMSNEWAMSTERDAM PHARMA CO NV$154.9M2.05%$20.58$34.83+69.2%
2.0%
RXRXRECURSION PHARMACEUTICALS-A$115.4M1.53%$7.46$3.80-49.1%
1.5%
ETNB89BIO INC$113.5M1.50%β€”β€”
1.5%
VRNAVERONA PHARMA PLC - ADR$110.4M1.46%β€”β€”
1.5%
DAWNDAY ONE BIOPHARMACEUTICALS I$108.5M1.43%β€”β€”
1.4%
FDMT4D MOLECULAR THERAPEUTICS IN$107.0M1.42%$21.34$13.00-39.1%
1.4%
SPRYARS PHARMACEUTICALS INC$92.4M1.22%$8.73$8.56-1.9%
1.2%
WVEWAVE LIFE SCIENCES LTD$90.8M1.20%$5.24$6.26+19.5%
1.2%
LBPHLONGBOARD PHARMACEUTICALS IN$88.9M1.18%β€”β€”
1.2%
ACLXARCELLX INC$88.5M1.17%$53.60β€”
1.2%
AXSMAXSOME THERAPEUTICS INC$80.5M1.06%$81.03$244.31+201.5%
1.1%
APGEAPOGEE THERAPEUTICS INC$77.2M1.02%$38.58$132.91+244.5%
1.0%
GHRSGH RESEARCH PLC$77.0M1.02%$11.75$27.01+129.9%
1.0%
GPCRSTRUCTURE THERAPEUTICS INC$74.5M0.99%$40.00$53.45+33.6%
1.0%
LENZLENZ THERAPEUTICS INC$72.3M0.96%$17.69$5.89-66.7%
1.0%

Quarter-on-Quarter Activity

Q2 2024 vs. Q1 2024

New Positions (8)

TickerIssuerNotionalSince Filing
RXRXRECURSION PHARMACEUTICALS-A$115.4M-49.1%
ACLXARCELLX INC$88.5M
CGONCG ONCOLOGY INC$44.1M
TRMLTOURMALINE BIO INC$32.6M
NRIXNURIX THERAPEUTICS INC$13.6M
INSMINSMED INC$13.4M
ZURAZURA BIO LTD$11.3M
NUVLNUVALENT INC-A$9.1M

Exited Positions (8)

TickerIssuerNotional
INBXINHIBRX INC$91.9M
MDGLMADRIGAL PHARMACEUTICALS INC$54.6M
CTKBCYTEK BIOSCIENCES INC$45.7M
VXRTVAXART INC$20.0M
EYPTEYEPOINT PHARMACEUTICALS INC$19.4M
BDTXBLACK DIAMOND THERAPEUTICS I$17.9M
IGMSIGM BIOSCIENCES INC$9.1M
CMPSCOMPASS PATHWAYS PLC$6.6M

Increased (8)

TickerIssuerNotionalShares Ξ”Since Filing
BCYCBICYCLE THERAPEUTICS PLC-ADR$25.7M+181.6%
CLYMELIEM THERAPEUTICS INC$187.4M+138.9%+83.0%
ACRVACRIVON THERAPEUTICS INC$14.0M+73.4%
RNAMAVIDITY BIOSCIENCES INC$136.8M+64.5%
ANROALTO NEUROSCIENCE INC$1.0M+50.5%
SERASERA PROGNOSTICS INC-A$-0.5M+49.8%
PRAXPRAXIS PRECISION MEDICINES I$0.6M+49.2%
EVHEVOLENT HEALTH INC - A$-25.3M+48.4%-69.0%

Trimmed (6)

TickerIssuerNotionalShares Ξ”Since Filing
CYBNXXXXCYBIN INC$-12.1M-24.3%
UNCYUNICYCIVE THERAPEUTICS INC$-3.5M-24.2%
ITOSITEOS THERAPEUTICS INC$-8.1M-20.4%
MGXMETAGENOMI INC$-12.4M-15.3%
CRVOCERVOMED INC$-6.1M-5.2%
APGEAPOGEE THERAPEUTICS INC$-54.2M-0.8%+244.5%
← Back to Hedge Funds